An evaluation suggested there was no overall net clinical benefit in patient them receiving the drug in the study , the company them said in a statement distributed by Business Wire .
An evaluation of 240 arthritis patient them suggested there was no overall net clinical benefit from taking the medicine , the company them said in a statement distributed by Business Wire .